Yes enough said.
I don't think people like Prof. Voit or the researchers behind the Rome Cohort study would have made commentary on P2 ATL1102 results if they thought it was trivial.
Let's get EMA ODD and get on with trial design for the 'pivotal' trial.
- Forums
- ASX - By Stock
- PER
- DMD results
DMD results, page-18
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
8.1¢ | 8.1¢ | 8.0¢ | $76.78K | 958.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 225430 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 45694 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 225430 | 0.079 |
1 | 10000 | 0.077 |
1 | 180000 | 0.076 |
4 | 186800 | 0.075 |
3 | 180866 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 10615 | 1 |
0.082 | 45694 | 2 |
0.084 | 770250 | 3 |
0.085 | 149809 | 2 |
0.086 | 480000 | 3 |
Last trade - 12.48pm 20/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |